ROSI, ELIA
 Distribuzione geografica
Continente #
NA - Nord America 1.055
AS - Asia 1.030
EU - Europa 560
SA - Sud America 107
AF - Africa 29
OC - Oceania 11
Totale 2.792
Nazione #
US - Stati Uniti d'America 1.014
CN - Cina 365
SG - Singapore 238
RU - Federazione Russa 182
PL - Polonia 108
VN - Vietnam 98
KR - Corea 97
HK - Hong Kong 82
BR - Brasile 76
IT - Italia 76
BD - Bangladesh 35
DE - Germania 35
FR - Francia 34
IE - Irlanda 30
JP - Giappone 27
IN - India 24
CA - Canada 19
SE - Svezia 19
GB - Regno Unito 15
JO - Giordania 12
AU - Australia 11
CH - Svizzera 11
BE - Belgio 10
MX - Messico 10
FI - Finlandia 9
AR - Argentina 8
AE - Emirati Arabi Uniti 7
NL - Olanda 7
TR - Turchia 7
UA - Ucraina 7
DK - Danimarca 5
IQ - Iraq 5
KE - Kenya 5
PY - Paraguay 5
VE - Venezuela 5
EC - Ecuador 4
ID - Indonesia 4
JM - Giamaica 4
NG - Nigeria 4
PH - Filippine 4
PK - Pakistan 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
BJ - Benin 3
CO - Colombia 3
DZ - Algeria 3
KG - Kirghizistan 3
NP - Nepal 3
SA - Arabia Saudita 3
CL - Cile 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ES - Italia 2
HR - Croazia 2
IL - Israele 2
PE - Perù 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
MA - Marocco 1
MN - Mongolia 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
Totale 2.792
Città #
Ashburn 211
Singapore 166
Santa Clara 144
Hefei 127
Warsaw 107
Seoul 96
Hong Kong 77
San Jose 62
Fairfield 58
Ann Arbor 41
The Dalles 38
Seattle 37
Ho Chi Minh City 32
Beijing 30
Dublin 29
Tokyo 25
Woodbridge 25
Chandler 23
Los Angeles 22
New York 21
Council Bluffs 20
Munich 20
Rome 20
Buffalo 18
Houston 18
Wilmington 16
Lauterbourg 15
Cambridge 14
Hanoi 13
Kent 12
Bern 11
Dallas 11
Florence 11
Brussels 9
Milan 9
Shenzhen 9
Bengaluru 8
Melbourne 8
São Paulo 8
Shanghai 7
Boardman 6
Chennai 6
Frankfurt am Main 6
Lawrence 6
Princeton 6
Toronto 6
Altamura 5
Haiphong 5
Moscow 5
Turku 5
Abuja 4
Asunción 4
Boston 4
Brasília 4
Chicago 4
Clifton 4
London 4
Mumbai 4
Naples 4
Orem 4
Paris 4
San Diego 4
Tianjin 4
Valby 4
Amsterdam 3
Bắc Giang 3
Cotonou 3
Helsinki 3
Nairobi 3
Redondo Beach 3
Rio de Janeiro 3
Tashkent 3
Thái Bình 3
Amman 2
Austin 2
Bakersfield 2
Barr 2
Bishkek 2
Bologna 2
Brooklyn 2
Bình Phước 2
Charlotte 2
Colmar 2
Columbus 2
Dakar 2
Davao City 2
Dearborn 2
Dong Ket 2
Fortaleza 2
Guangzhou 2
Guayaquil 2
Hillsboro 2
Hyderabad 2
Hải Dương 2
Jeddah 2
Kingston 2
Lahore 2
Lima 2
Macaé 2
Maracaibo 2
Totale 1.821
Nome #
Immunoglobulin replacement therapy for yellow nail syndrome 305
Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa 200
The Relevance of Family History Taking in the Detection and Management of Birt-Hogg-Dubé Syndrome 187
Does the body weight influence the outcome in children treated with robotic pyeloplasty? 181
Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of caspofungin in a population of critically ill septic patients 161
Polygenic Score: A Tool for Evaluating the Genetic Background of Sporadic Hidradenitis Suppurativa 158
Pharmacological properties of oral antibiotics for the treatment of uncomplicated urinary tract infections 151
Anti-Interleukin-17s for successful management of pustular psoriasis 107
Monozygotic twins affected by SAPHO syndrome 106
Comment on ‘Morphology: the mother of all biomarkers’ 105
Estimation of patients with psoriasis potentially eligible and currently untreated with biological drugs in Italy 98
Assessment of therapeutic response to photodynamic therapy with the Zn-Phthalocyanine RLP068/Cl versus topical Clindamycin in patients affected by Hidradenitis Suppurativa: a comparative clinical pilot study 94
Discoid lupus erythematosus affecting the scalp 94
The Relevant Oral Burden of Patients with Hidradenitis Suppurativa 90
Th2 Cytokines Affect the Innate Immune Barrier without Impairing the Physical Barrier in a 3D Model of Normal Human Skin 88
Therapy of PsO in Special Subsets of Patients 87
Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort Study 81
Effects on Lipid Profile after One Year of Apremilast Therapy in Patients with Psoriasis: A Monocentric Experience 76
Psoriasis Flare in a Liver Transplant Patient: A Case Report of a Successful Treatment With Apremilast 73
Hidradenitis Suppurativa: The Influence of Gender, the Importance of Trigger Factors and the Implications for Patient Habits 59
REDUCED SLEEP QUALITY AND DECREASED EXECUTIVE PERFORMANCE IN PATIENTS WITH PSORIASIS 49
Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study 39
SUBJECTIVE SLEEP QUALITY IN PSORIATIC PATIENTS AND ITS ASSOCIATION WITH SYMPTOMS SEVERITY 25
Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation 24
Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas 23
Risankizumab in very elderly patients in real-world practice 20
Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study 19
Rethinking antibiotic use in hidradenitis suppurativa: a call for stewardship 18
Drug survival, long-term safety and efficacy of anti-TNF-alpha biosimilars: a monocentric retrospective study 18
Azathioprine-induced acute generalized exanthematous pustulosis in a woman with autoimmune hepatitis 16
Risankizumab in Oncologic Patients With Psoriasis: A Case Series 16
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study 15
Erythema multiforme as a rare skin manifestation during pembrolizumab treatment: a case report and literature review 14
Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa 13
Long-term, real-world effectiveness of adalimumab in the treatment of hidradenitis suppurativa 11
Fibrillar pattern as ultrasonographic progression biomarker of hidradenitis suppurativa 8
Targeting IL-17A for the treatment of pustular psoriasis: a comprehensive review 7
Totale 2.836
Categoria #
all - tutte 7.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.152


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 0 0 0 0 0 0 0 0 6
2021/202250 3 0 2 5 1 2 4 4 3 5 7 14
2022/2023130 14 19 10 6 8 18 15 4 18 0 5 13
2023/202438 3 2 5 1 2 10 1 5 1 3 2 3
2024/2025568 16 27 21 54 113 81 43 47 46 11 43 66
2025/20261.693 207 226 242 137 144 37 138 100 178 136 133 15
Totale 2.836